And so, the waiting begins
The drugs achieve these benefits by mimicking GLP-1s effects: They stimulate insulin production by binding to beta-cells in the pancreas
We want every member of the diverse T1D community to be aware of clinical trials, how to participate, and where to find information
[2] [3] These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)with tirzepatide being a dual GIP/GLP-1 receptor agonist rather than a pure GLP-1 agonist
A sum of all frames, filtered according to the exposure dose, in each image stack was used for further processing